|
|
|
|
|
|
|
|
|
|
|
|
|
|
S.B. 474 VETOES
tests; authorizing certain optometrists to administer or prescribe certain
steroids under certain circumstances; requiring the State Board of Examiners in
Optometry to approve certain continuing education courses by a certain date;
requiring the Board to grant a waiver of certain requirements under this Act to
certain individual until a certain date; requiring the Board to certify certain
optometrists; requiring the Board to adopt a certain practice protocol in
consultation with and subject to the approval of the State Board of Physicians by
a certain date; requiring the Board to report to certain committees of the
General Assembly by a certain date; and generally relating to the State Board of
Examiners in Optometry.
BY repealing and reenacting, with amendments,
Article - Health Occupations
Section 11-404.1 and 11-404.2
Annotated Code of Maryland
(2000 Replacement Volume and 2004 Supplement)
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF
MARYLAND, That the Laws of Maryland read as follows:
Article - Health Occupations
11-404.1.
(a) Unless certified under this section, a licensed optometrist may not
administer or prescribe any therapeutic pharmaceutical agents or remove superficial
foreign bodies from a human eye, adnexa, or lacrimal system.
(b) (1) Except as provided in paragraph (2) of this subsection, the Board
shall certify a licensed optometrist as a therapeutically certified optometrist if the
licensed optometrist submits to the Board evidence satisfactory to the Board that the
licensed optometrist:
(i) Has successfully completed at least 110 hours of a therapeutic
pharmaceutical agents course approved by the Board;
(ii) Has successfully passed a pharmacology examination relating
to the treatment and management of ocular disease, which is prepared, administered,
and graded by the National Board of Examiners in Optometry or any other nationally
recognized optometric organization as approved by the Secretary; [and]
(iii) Is currently certified by the Board to administer topical ocular
diagnostic pharmaceutical agents under § 11-404 of this subtitle; AND
(IV) HAS SUCCESSFULLY COMPLETED A 24-HOUR AN 8-HOUR
COURSE IN THE MANAGEMENT OF TOPICAL PHARMACEUTICAL AGENTS AND THE
REMOVAL OF RESIDUAL PARTICULATE MATTER THROUGH THE USE OF AN ALGER
BRUSH STEROIDS APPROVED BY THE BOARD.
|
|
|
|
|
|
|
|
|
|
- 3654 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
